Analyst Ratings for BiondVax Pharmaceuticals (BVXV)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/26/2015 | Aegis Capital | N/A | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.97 (1.36) |
-72.64% | Details |
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/26/2015 | Aegis Capital | N/A | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.97 (1.36) |
-72.64% | Details |